Finally, since the platelet function is enhanced in T2D patients, the increased levels of PAI-1 (plasminogen activator inhibitor type 1) are considered to be a risk factor of cardiovascular diseases in these patients [23]. Here, SERPINE1 is linked to type 2 diabetes mellitus.